NOT KNOWN FACTUAL STATEMENTS ABOUT HASTATOSIDE

Even though five-FU is one of the most broadly applied chemotherapeutic reagents to the procedure of various sorts of most cancers, it is not used for the treatment of HCC except in combination with cisplatin as hepatic arterial infusion chemotherapy in certain areas. Among the list of major causes for This can be five-FU resistance in HCC, and it